The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS?

Saved in:
Bibliographic Details
Title: The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS?
Authors: Mavlyutov TA; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Baker EM; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Losenegger TM; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Kim JR; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Torres B; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Epstein ML; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA., Ruoho AE; Department of Neuroscience, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA. aeruoho@wisc.edu.
Source: Advances in experimental medicine and biology [Adv Exp Med Biol] 2017; Vol. 964, pp. 255-265.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Kluwer Academic/Plenum Publishers Country of Publication: United States NLM ID: 0121103 Publication Model: Print Cited Medium: Print ISSN: 0065-2598 (Print) Linking ISSN: 00652598 NLM ISO Abbreviation: Adv Exp Med Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0065-2598
DOI:10.1007/978-3-319-50174-1_17